BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22412199)

  • 1. LAPTM4B polymorphisms is associated with ovarian cancer susceptibility and its prognosis.
    Xu Y; Liu Y; Zhou R; Meng F; Gao Y; Yang S; Li X; Yang M; Lou G
    Jpn J Clin Oncol; 2012 May; 42(5):413-9. PubMed ID: 22412199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
    Jin X; Kang S; Wang N; Xing YP; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of LAPTM4B gene polymorphism with breast cancer susceptibility.
    Fan M; Liu Y; Zhou R; Zhang Q
    Cancer Epidemiol; 2012 Aug; 36(4):364-8. PubMed ID: 22270081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAPTM4B gene polymorphism and endometrial carcinoma risk and prognosis.
    Meng F; Li H; Zhou R; Luo C; Hu Y; Lou G
    Biomarkers; 2013 Mar; 18(2):136-43. PubMed ID: 23312008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAPTM4B polymorphism is associated with non‑small cell lung cancer susceptibility and prognosis.
    Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M; Hu W
    Oncol Rep; 2014 May; 31(5):2454-60. PubMed ID: 24676601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.
    Yang Y; Yang H; McNutt MA; Xiong F; Nie X; Li L; Zhou R
    Oncol Rep; 2008 Nov; 20(5):1077-83. PubMed ID: 18949404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer.
    Liu Y; Zhang QY; Qian N; Zhou RL
    Ann Oncol; 2007 Feb; 18(2):311-6. PubMed ID: 17074969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
    Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
    Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of LAPTM4B polymorphisms with cervical carcinoma.
    Meng F; Song H; Luo C; Yin M; Xu Y; Liu H; Zhou R; Lou G
    Cancer; 2011 Jun; 117(12):2652-8. PubMed ID: 21656743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.
    Cheng X; Tian X; Wu X; Xing X; Du H; Zhou C; Zhang Q; Hao C; Wen X; Ji J
    PLoS One; 2016; 11(7):e0158715. PubMed ID: 27391361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of interleukin-23 receptor gene polymorphisms with risk of ovarian cancer.
    Zhang Z; Zhou B; Zhang J; Chen Y; Lai T; Yan L; Liang A; Li Y; Wang Y; Chen Y; Zhang L; Xi MR
    Cancer Genet Cytogenet; 2010 Jan; 196(2):146-52. PubMed ID: 20082850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
    Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
    J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
    Liang J; Li Y; Wang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma.
    Zhai G; Yan K; Ji X; Xu W; Yang J; Xiong F; Su J; McNutt MA; Yang H
    PLoS One; 2012; 7(9):e45290. PubMed ID: 22984631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis.
    Li X; Kong X; Chen X; Zhang N; Jiang L; Ma T; Yang Q
    PLoS One; 2012; 7(9):e44916. PubMed ID: 22984585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
    Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
    Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
    Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
    Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of lysosomal protein transmembrane 4 beta gene polymorphism with pancreatic carcinoma susceptibility in the Chinese population.
    Wang B; Wang S; Liang G; Xu J; Zhou R; Zhang Q
    Tumour Biol; 2017 Jun; 39(6):1010428317705518. PubMed ID: 28618967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between LAPTM4B gene polymorphism and susceptibility of lung cancer].
    Deng LJ; Zhang QY; Liu B; Zhou RL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):302-5. PubMed ID: 15968325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers.
    Cheng XJ; Xu W; Zhang QY; Zhou RL
    Ann Oncol; 2008 Mar; 19(3):527-32. PubMed ID: 17965115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.